Brii Biosciences Limited BRIBF
0.13 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
0.2312 Day range 0.2459
0.12575 52-week range 0.2459
- YTD
- -30.37%
- 1 year
- -45.97%
- Market cap
- 93.80M
- EPS (ttm)
- -0.04
- YTD return
- -30.37%
- 1-year return
- -45.97%
- Volume
- 4.15K
- Avg volume
- 37
- Open
- 0.2459
- Previous close
- 0.13
- Day's range
- 0.2312 – 0.2459
- 52-week range
- 0.12575 – 0.2459
2Y +0.0045 (+3.59%)
News
Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV 
Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026 
Brii Biosciences Limited (BRIBF) Q4 2025 Earnings Call Transcript 
Brii Biosciences Provides Corporate Updates and Reports Full Year 2025 Financial Results 
Brii Biosciences Announces Publication of Phase 2 ENSURE Study Results in Nature Medicine 
Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results 
Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China 
Brii Bio Presents Late-Breaking Data from Its Ongoing Phase 2 ENSURE Study at EASL Congress 2025, Suggesting BRII-179's Role in Advancing Higher HBsAg Loss 
Brii Bio Unveils New Data from Its Ongoing Phase 2 ENSURE Study at APASL 2025, Showcasing BRII-179's Unique Potential to Prime and Boost Higher HBsAg Loss Through Target Patient Identification 
Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results
Your note
Sign in to keep a note on BRIBF — it syncs with the Stock Master app.